Trial intelligence / Profile preview

Influenza vaccine response in ESRD patients: HD vs HDF

NCT04122222Completed

Sponsor
Mahidol University
Start
Aug 2016
Primary completion
Jul 2018
Modality
Vaccines & Immunotherapeutics
01

Overview

Open-label trial of influenza vaccine in influenza, sponsored by Mahidol University. Primary endpoint: Antibody titers determined by hemagglutination inhibition assay at 12 months. Started Aug 2016; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT04122222.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04122222.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call